In Industry Insights, members of ASPET’s Industry Science Committee discuss the intersection of pharmacology and industry, private sector highlights, and how the industry and membership can support each other.
The Importance of Assay Development in Pharmacology
By R. Kyle Palmer, PhD and Harshini Neelakantan, PhD
ISC Founding Co-Chairs
Pharmacology advances through controlled experimentation and rigorous quantitative analysis. Pharmacologists know from practical experience that arriving at sound conclusions from experimental results is critically dependent on the quality and reliability of the assay used to examine the phenomenon of interest. An assay is a complete system of methods, reagents, instrumentation, and controls used together following a defined protocol to detect an analyte or establish a functional relationship. Pharmacologists routinely modify existing assays to meet research objectives and occasionally develop and validate entirely novel assays. But developing a reliable assay is a painstaking process, and there are key performance characteristics that mark a good assay.
Define What is Measured
Assay development begins by clearly defining independent and dependent variables and their units of measurement. Units of the variables can be relatively straightforward and standardized—concentration, time, and fluorescence or absorbance, for example. Defining units for dependent variables of pharmacodynamic assays, however, becomes increasingly challenging as the focus moves from the molecular level to complicated physiological systems and behavior. Regardless, the goal for functional assay development should be a dependent variable that is objectively verifiable with measurable dimensions, a task that could require the invention of new instruments for measurement. The invention of the operant chamber is a classic illustration of this principle: complex behavior was reduced to a quantifiable objective response—the lever press.
Establish Assay Validation and Reliability
Validation establishes whether an assay measures its intended biological process, under what conditions, and with what limitations. The assay must operate within a well-reasoned theoretical context, preferably one that is founded and described by quantitative laws. In this regard, pharmacological assays are advantaged by the foundational laws of mass-action, receptor occupancy, and the concept of efficacy. For example, a pharmacodynamic assay must demonstrate saturability, a property that arises from the finite numbers of receptors available for ligand binding. If the assay output faithfully reflects the underlying process, the assay has construct validity.
Reliability is the degree to which an assay produces consistent results when repeated under the same conditions (repeatability) and by different investigators or laboratories (reproducibility). The repeatability for a pharmacodynamic assay can be statistically defined by the limits of agreement test, determined by the geometric average fold-difference in potency across two tests of a concentration-response relationship. Pharmacodynamic reproducibility can be quantified by the minimum significant ratio (MSR), the smallest potency ratio statistically detectable between two compounds. The ultimate test of assay reliability is transferability, an assay’s ability to perform equivalently in a new lab. For potency assays, a lab-to-lab MSR is a common way to quantify transferability.
From Reliable Assays to Automated Screening
Once an assay is validated, miniaturization into multi-well formats can enable high-throughput screening (HTS) in drug discovery, but simply reducing reaction volume is not enough. Signal quality, reagent stability, edge effects, liquid-handling precision, and plate-to-plate variability must be re-evaluated before integrating automated dispensing, incubation, detection, and data analysis. For example, a noncoupled fluorescent assay that directly monitors an enzymatic product formation in real time, eliminating a secondary coupled reaction, provides a streamlined detection strategy that can support adaptation to screening workflows, subject to HTS-specific validation.
Patentability of Novel Assays
An assay may be patentable when it incorporates a novel, nonobvious, useful, and adequately described technical invention, such as for a new detection chemistry, engineered reagent, novel instrumentation, or inventive measurement method. In contrast, applying established assays to new targets, adjusting assay conditions, or using off-the-shelf reagents within existing conceptual frameworks to novel assays do not support patentability.
Conclusion and Further Reading
Reliable assays are indispensable tools for pharmacologists to translate scientific discoveries. This article has touched on only the basics of good assay development. For more in-depth discussion, the reader is referred to the guidelines published on the website for the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ich.org) and the National Institutes of Health Assay Guidance Manual (available through PubMed, NCBI Bookshelf).


